Association between intestinal and antioxidant barriers in children with cancer.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Acta Biochimica Polonica

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.18388/ABP.2012_2144PMID 22577621
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The antioxidant status and response to therapy in children with soft tissue sarcomas and neuroblastoma

  2011cited by this paper
• Ischemia‐modified albumin as a biochemical marker in children with neuroblastoma and soft tissue sarcomas

  2011cited by this paper
• Oxidative stress and enhanced paracellular permeability in the small intestine of methotrexate-treated rats

  2010cited by this paper
• Altered antioxidant status and lipid peroxidation in Indian patients with urothelial bladder carcinoma.

  2010cited by this paper
• Evaluation of ischemia-modified albumin in myocardial infarction and prostatic diseases.

  2009cited by this paper
• Citrulline as a marker for chemotherapy induced mucosal barrier injury in pediatric patients

  2009cited by this paper
• Imaging of the gastrointestinal complications of systemic chemotherapy.

  2009cited by this paper
• Butyrate modulates oxidative stress in the colonic mucosa of healthy humans.

  2009cited by this paper
• Cancer-related inflammation

  2008cited by this paper
• Influence of therapy on the antioxidant status in patients with melanoma

  2008cited by this paper
• Intestinal permeability and its association with the patient and disease characteristics in Crohn's disease.

  2008cited by this paper
• Evaluation of ischemia‐modified albumin in anemia associated to chronic kidney disease

  2008cited by this paper
• Clinical utility of the cobalt-albumin binding assay in the diagnosis of intestinal ischemia.

  2008cited by this paper
• Nuclear factor-kappaB activation: from bench to bedside.

  2008cited by this paper
• Gut permeability to lactulose and mannitol differs in treated Crohn's disease and celiac disease patients and healthy subjects.

  2008cited by this paper
• Gastrointestinal permeability in ovarian cancer and breast cancer patients treated with paclitaxel and platinum

  2007cited by this paper
• Antioxidant status in advanced cervical cancer patients undergoing neoadjuvant chemoradiation

  2007cited by this paper
• Nuclear Factor-jB Activation: From Bench to Bedside

  2007cited by this paper
• The Immune Response in Inflammatory Bowel Disease

  2007cited by this paper
• Application of albumin-adjusted ischemia modified albumin index as an early screening marker for acute coronary syndrome.

  2007cited by this paper
• Standardization of ischemia-modified albumin testing: adjustment for serum albumin

  2007cited by this paper
• Roles of ZO-1, occludin, and actin in oxidant-induced barrier disruption.

  2006cited by this paper
• Ischemia-Modified Albumin Concentrations Should Be Interpreted with Caution in Patients with Low Serum Albumin Concentrations

  2006cited by this paper
• Antioxidant Enzyme Activities and Lipid Peroxidation Levels in Erythrocytes of Patients with Oesophageal and Gastric Cancer

  2006influential reference
• Intestinal Permeability in the Assessment of Intestinal Toxicity of Cytotoxic Agents

  2005cited by this paper
• Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome.

  2005cited by this paper
• Role of reactive oxygen species on the formation of the novel diagnostic marker ischaemia modified albumin

  2005cited by this paper
• Cancer-associated malnutrition.

  2005cited by this paper
• Intestinal permeability is decreased in anorexia nervosa

  2004cited by this paper
• The pathobiology of mucositis.

  2004cited by this paper
• Role of oxidative modifications in atherosclerosis.

  2004cited by this paper
• The pathobiology of mucositis

  2004cited by this paper
• Oxidative stress contributes to methotrexate-induced small intestinal toxicity in rats

  2004cited by this paper
• Perspectives on cancer therapy‐induced mucosal injury

  2004cited by this paper
• Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction.

  2003cited by this paper
• Superoxide radical generation and Mn‐ and Cu‐Zn superoxide dismutases activities in human leukemic cells

  2003cited by this paper
• Role of Phosphatidylinositol 3-Kinase in Oxidative Stress-induced Disruption of Tight Junctions*

  2003cited by this paper
• The burdens of cancer therapy

  2003cited by this paper
• Diagnosis of Intestinal Ischemia.

  2002cited by this paper
• Characterization of the Co(2+) and Ni(2+) binding amino-acid residues of the N-terminus of human albumin. An insight into the mechanism of a new assay for myocardial ischemia.

  2001cited by this paper
• Effect of a synthetic analog of prostaglandin E1 on the intestinal mucosa of methotrexate-treated rats.

  2001influential reference
• Lactulose-mannitol intestinal permeability test in children with diarrhea caused by rotavirus and cryptosporidium. Diarrhea Working Group, Peru.

  2000cited by this paper
• Superoxide dismutase as a target for the selective killing of cancer cells

  2000cited by this paper
• Free radicals antioxidant enzymes and lipid peroxidation in different types of leukemias.

  2000cited by this paper
• Lactulose–Mannitol Intestinal Permeability Test in Children With Diarrhea Caused by Rotavirus and Cryptosporidium

  2000cited by this paper
• Case Report: Diffuse Mucosal Damage in the Large Intestine Associated with Irinotecan (CPT-11)

  1998cited by this paper
• Erythrocyte Lipid Peroxidation and Antioxidants in Gastric Cancer Patients

  1997cited by this paper
• Importance of Se-glutathione peroxidase, catalase, and Cu/Zn-SOD for cell survival against oxidative stress.

  1994cited by this paper
• Multiple organ failure. Pathophysiology and potential future therapy.

  1992cited by this paper
• Automated enzymatic assays for the determination of intestinal permeability probes in urine. 1. Lactulose and lactose.

  1990cited by this paper
• Automated enzymatic assays for the determination of intestinal permeability probes in urine. 2. Mannitol.

  1989cited by this paper
• Intestinal permeability in patients with Crohn's disease and their healthy relatives.

  1989cited by this paper
• Intestinal permeability during chemotherapy for childhood tumours

  1988cited by this paper
• Complications of abdominal operations for malignant disease.

  1988cited by this paper
• Small bowel function in acute lymphoblastic leukaemia.

  1984cited by this paper
• Intestinal permeability in children with Crohn's disease and coeliac disease.

  1982cited by this paper
• Multiple organ failure.

  1977cited by this paper
• [The epithelium of the small intestine].

  1975cited by this paper

• Droplet digital PCR quantifies host inflammatory transcripts in feces reliably and reproducibly

  2016cites this paper
• The association between ischaemia-modified albumin levels in umbilical vein and intrauterine growth restriction

  2015cites this paper
• Oxidative Stress Biomarkers: Current Status and Future Perspective

  2014cites this paper